268 related articles for article (PubMed ID: 27741435)
1. Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.
Marinkovic M; Horeweg N; Fiocco M; Peters FP; Sommers LW; Laman MS; Bleeker JC; Ketelaars M; Luyten GP; Creutzberg CL
Eur J Cancer; 2016 Nov; 68():106-113. PubMed ID: 27741435
[TBL] [Abstract][Full Text] [Related]
2. The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone.
Yarovoy AA; Magaramov DA; Bulgakova ES
Brachytherapy; 2012; 11(3):224-9. PubMed ID: 22104351
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
[TBL] [Abstract][Full Text] [Related]
4. [Tumor regression in malignant choroidal melanomas after transpupillary thermotherapy (TTT) versus ruthenium brachytherapy and sandwich therapy - a comparative analysis].
Stoffelns BM; Schoepfer K; Jochem T; Faldum A
Klin Monbl Augenheilkd; 2010 Apr; 227(4):262-8. PubMed ID: 20408070
[TBL] [Abstract][Full Text] [Related]
5. Transpupillary thermotherapy in choroidal melanomas.
Oosterhuis JA; Journée-de Korver HG; Kakebeeke-Kemme HM; Bleeker JC
Arch Ophthalmol; 1995 Mar; 113(3):315-21. PubMed ID: 7887845
[TBL] [Abstract][Full Text] [Related]
6. Combined brachytherapy and transpupillary thermotherapy for large choroidal melanoma: tumor regression and early complications.
Kreusel KM; Bechrakis N; Riese J; Krause L; Wachtlin J; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1575-80. PubMed ID: 16738857
[TBL] [Abstract][Full Text] [Related]
7. [Results of 10-year use of complex treatment of choroidal melanoma stage T2 with brachytherapy and transpupillary thermotherapy].
Iarovoĭ AA; Magaramov DA; Bulgakova ES
Vestn Oftalmol; 2011; 127(1):38-42. PubMed ID: 21539104
[TBL] [Abstract][Full Text] [Related]
8. Transpupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas.
Harbour JW; Meredith TA; Thompson PA; Gordon ME
Ophthalmology; 2003 Nov; 110(11):2207-14; discussion 2215. PubMed ID: 14597531
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium-106 plaque radiotherapy alone or in combination with transpupillary thermotherapy in the management of choroidal melanoma.
Gündüz K; Kurt RA; Akmeşe HE; Köse K; Uçakhan-Gündüz O
Jpn J Ophthalmol; 2010 Jul; 54(4):338-43. PubMed ID: 20700803
[TBL] [Abstract][Full Text] [Related]
10. Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience.
Bartlema YM; Oosterhuis JA; Journée-De Korver JG; Tjho-Heslinga RE; Keunen JE
Br J Ophthalmol; 2003 Nov; 87(11):1370-3. PubMed ID: 14609837
[TBL] [Abstract][Full Text] [Related]
11. [Transpupillary thermotherapy of choroidal melanoma].
Schneider H; Fischer K; Fietkau R; Guthoff RF
Klin Monbl Augenheilkd; 1999 Feb; 214(2):90-5. PubMed ID: 10218201
[TBL] [Abstract][Full Text] [Related]
12. Transpupillary thermotherapy as an adjunct to ruthenium plaque radiotherapy for choroidal melanoma.
Seregard S; Landau I
Acta Ophthalmol Scand; 2001 Feb; 79(1):19-22. PubMed ID: 11167280
[TBL] [Abstract][Full Text] [Related]
13. Extended follow-up of small melanocytic choroidal tumors treated with transpupillary thermotherapy.
Win PH; Robertson DM; Buettner H; McCannel CA; Bennett SR
Arch Ophthalmol; 2006 Apr; 124(4):503-6. PubMed ID: 16606875
[TBL] [Abstract][Full Text] [Related]
14. [Prospective nonrandomised analysis of "Sandwich Therapy" for malignant melanoma of the choroid].
Stoffelns BM; Kutzner J; Schöpfer K; Frising M
Klin Monbl Augenheilkd; 2002 Apr; 219(4):211-5. PubMed ID: 12022003
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of transpupillary thermotherapy as primary treatment of selected choroidal melanoma.
Parrozzani R; Boccassini B; De Belvis V; Radin PP; Midena E
Acta Ophthalmol; 2009 Nov; 87(7):789-92. PubMed ID: 18778335
[TBL] [Abstract][Full Text] [Related]
16. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium-106 plaque brachytherapy for uveal melanoma.
Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
[TBL] [Abstract][Full Text] [Related]
18. Which choroidal melanoma should be treated with primary transpupillary thermotherapy? Our experience from 78 patients.
Yarovoy AA; Magaramov DA; Bulgakova ES
Eur J Ophthalmol; 2010; 20(1):186-93. PubMed ID: 19882517
[TBL] [Abstract][Full Text] [Related]
19. Visual acuity, oncologic, and toxicity outcomes with
Patel KR; Prabhu RS; Switchenko JM; Chowdhary M; Craven C; Mendoza P; Danish H; Grossniklaus HE; Aaberg TM; Aaberg T; Reddy S; Butker E; Bergstrom C; Crocker IR
Brachytherapy; 2017; 16(3):646-653. PubMed ID: 28262517
[TBL] [Abstract][Full Text] [Related]
20. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control.
Mashayekhi A; Shields CL; Rishi P; Atalay HT; Pellegrini M; McLaughlin JP; Patrick KA; Morton SJ; Remmer MH; Parendo A; Schlitt MA; Shields JA
Ophthalmology; 2015 Mar; 122(3):600-9. PubMed ID: 25439431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
